Artificial Intelligence
The Global Urinary Stents Market to Register Sustainable Growth at a CAGR of ~6% by 2027 | DelveInsight
<!– Name:DistributionId Value:8810155 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value: –> <!– Name:CustomerId Value:1204938 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:a0d01f17-5a6e-4d71-ae7c-f90132efaeab –>
New York, USA, April 18, 2023 (GLOBE NEWSWIRE) — The Global Urinary Stents Market to Register Sustainable Growth at a CAGR of ~6% by 2027 | DelveInsight
The urinary stents market is expanding due to several factors, including an increase in the prevalence of kidney diseases, an increase in the prevalence of bladder cancer, an increase in regulatory approvals for urinary stents, and an increase in the global geriatric population.
DelveInsight’s Urinary Stents Market Insights report provides the current and forecast market analysis, individual leading urinary stents companies’ market shares, challenges, urinary stents market drivers, barriers, and trends, and key urinary stents companies in the market.
Key Takeaways from the Urinary Stents Market Report
- As per DelveInsight estimates, North America is anticipated to dominate the global urinary stents market during the forecast period.
- Notable urinary stents companies such as Allium Medical Solutions Ltd, Boston Scientific Corporation, B. Braun Melsungen AG, Cook, Coloplast Corp, BD, Medline Industries LP, Olympus America, Pnn Medical A/S, Teleflex Incorporated, Biomerics, UROMED Kurt Drews KG, TAEWOONG, Applied Medical Resources Corporation, GBUK Group Ltd, Dornier MedTech America Inc, Rocamed, HydrUStent SA, Blue Neem Medical Devices Pvt Ltd, ACE Medical Devices Pvt. Ltd, and several others, are currently operating in the urinary stents market.
- In February 2023, Boston Scientific Corporation announced that the FDA had granted the LithoVue Elite Single-Use Digital Flexible Ureteroscope System 510(k) clearance.
- In September 2022, UroGen Pharma Ltd., a biotech company dedicated to developing and commercializing innovative solutions to treat urothelial and specialty cancers, announced that the U.S. Food and Drug Administration (FDA) had authorized an extension of the in-use period for JELMYTO® (mitomycin) for pelvicalyceal solution admixture from 8 hours to 96 hours (four days) following product reconstitution.
- In May 2022, the US FDA granted its 510k approval for a novel urinary stent developed by Dean Secrest and Lee Ponsky, MD, Chair of the Department of Urology and Leo & Charlotte Goldberg Chair in Advanced Surgical Therapies at University Hospitals (UH) in Cleveland.
To read more about the latest highlights related to the urinary stents market, get a snapshot of the key highlights entailed in the Global Urinary Stents Market Report
Urinary Stents Overview
A ureteral stent is a thin tube that is inserted into the ureter to prevent or treat kidney urine flow blockage. This procedure restores urine flow through blocked ureters while keeping kidney functions normal. These devices are implanted during or after treating kidney stones, tumors, or urinary incontinence. The ureteral stent is removed following the treatment procedure. Kidney transplantation is frequently associated with vesicoureteral complications, stenosis, and ureter tube obstruction. Ureteral stents are used to reduce complications associated with renal transplantation, such as urine leaks, ureteric stenosis, or obstruction. For example, a double-J ureteral stent successfully treats minor ureteric leaks and transplant ureter obstruction.
Urinary Stents Market Insights
North America dominated the global urinary stents market in 2021 and will continue to do so during the forecast period of 2022–2027. Factors such as the rising prevalence of kidney disease drive demand for urinary stents in the North American urinary stents market. Furthermore, an increase in regulatory approvals for urinary stents could drive the overall urinary stents market in the region. For example, in May 2022, the US FDA granted 510k approval to Dean Secrest and Lee Ponsky, MD, Chair of the Department of Urology, and Leo & Charlotte Goldberg, Chair in Advanced Surgical Therapies at University Hospitals (UH) in Cleveland. The ReliefTM Stent can now be sold in the United States to people suffering from kidney stones and other conditions that make it difficult for the kidney to drain urine.
To know more about why North America is leading the market growth in the urinary stents market, get a snapshot of the Urinary Stents Market Outlook
Urinary Stents Market Dynamics
The rising prevalence of kidney diseases such as kidney stones is one of the primary drivers of the urinary stents market. Furthermore, the rising prevalence of bladder cancer around the world is driving the growth of the urinary stents market.
However, the high cost of ureteral stent placement and the negative effects associated with ureteral stents, such as bladder irritation, Urinary Tract Infections (UTI), and others, may limit the global urinary stents market growth.
Additionally, the COVID-19 epidemic has had a negative impact on the ureteral stents market. The nationwide lockdown in almost every country-restricted people’s movement and hospital visits, halted supply chains and logistics, hampered the manufacturing process, resulting in a product shortage in the market, and elective surgeries were also halted and were not given priority treatment because COVID-19 patients were given priority. However, with the mass vaccination of the population, relaxation of lockdown restrictions, resumption of supply chains, logistics, and manufacturing units, and an increase in elective surgeries, the ureteral stents market has gained traction and is expected to grow further during the forecast period.
Get a sneak peek at the urinary stents market dynamics @ Urinary Stents Market Dynamics Analysis
Report Metrics | Details |
Coverage | Global |
Study Period | 2019–2027 |
Base Year | 2021 |
Urinary Stents Market CAGR | ~6% |
Projected Urinary Stents Market Size by 2027 | USD 612.87 Million |
Key Urinary Stents Companies | Allium Medical Solutions Ltd, Boston Scientific Corporation, B. Braun Melsungen AG, Cook, Coloplast Corp, BD, Medline Industries LP, Olympus America, Pnn Medical A/S, Teleflex Incorporated, Biomerics, UROMED Kurt Drews KG, TAEWOONG, Applied Medical Resources Corporation, GBUK Group Ltd, Dornier MedTech America Inc, Rocamed, HydrUStent SA, Blue Neem Medical Devices Pvt Ltd, ACE Medical Devices Pvt. Ltd, among others |
Urinary Stents Market Assessment
- Urinary Stents Market Segmentation
- Market Segmentation By Product: Open-Ended, Close-Ended Double Pigtail, Double Loop Stent, and Others
- Market Segmentation By Material: Polymer, Metal, Polyurethane, Silicone, and Others
- Market Segmentation By Application: Kidney Stones, Inflammatory Bowel Disease, Tumors, and Others
- Market Segmentation By End User: Hospitals, Ambulatory Surgical Centres, and Others
- Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the urinary stents market are set to emerge as the trendsetter explore @ Urinary Stents Companies
Table of Contents
1 | Report Introduction |
2 | Executive summary |
3 | Regulatory and Patent Analysis |
4 | Key Factors Analysis |
5 | Porter’s Five Forces Analysis |
6 | COVID-19 Impact Analysis on Urinary Stents Market |
7 | Urinary Stents Market Layout |
8 | Global Company Share Analysis – Key 3-5 Companies |
9 | Urinary Stents Market Company and Product Profiles |
10 | Project Approach |
11 | About DelveInsight |
Interested in knowing the urinary stents market by 2027? Click to get a snapshot of the Urinary Stents Market Trends
Related Reports
Stress Urinary Incontinence Market
Stress Urinary Incontinence Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key stress urinary incontinence companies, including Adrian Gaspar, Gynamics LTD, Solace Therapeutics, Inc., among others.
Stress Urinary Incontinence Pipeline
Stress Urinary Incontinence Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key stress urinary incontinence companies, including Adrian Gaspar, Gynamics LTD, Solace Therapeutics, Inc., among others.
Urinary Incontinence Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key urinary incontinence companies, including Ixaltis SA, Graminex LLC, KGK Science Inc., among others.
Urinary Incontinence Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key urinary incontinence companies, including Ixaltis SA, Graminex LLC, KGK Science Inc., among others.
Uncomplicated Urinary Tract Infections Market
Uncomplicated Urinary Tract Infections Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, market share of the individual therapies, and key uncomplicated urinary tract infections companies, including Venatorx Pharmaceuticals, Allecra Therapeutics, Nabriva Therapeutics AG, MerLion Pharmaceuticals, among others.
Complicated Urinary Tract Infections Pipeline
Complicated Urinary Tract Infections Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, including clinical and non-clinical stage products and the key complicated urinary tract infections companies, including Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, among others.
Other Trending Reports
Treatment Resistant Depression Market | Advanced Renal Cell Carcinoma Market | Brain Cancer Market | Centronuclear Myopathy Market | Head And Neck Squamous Cell Carcinoma Market | Acquired Immunodeficiency Syndrome Market | Acute Intermittent Porphyria Market | Neurovascular Devices Market | Defibrillators Market | Ventricular Hypertrophy Market | Urolithiasis Market | Alopecia Areata Market | Autonomic Dysfunction Market | Acute Ischemic Stroke Ais Market | Adenoid Cystic Carcinoma Market | Aspergillosis Market | Biliary Atresia Market | Biliary Tumor Market | Chronic Inducible Urticaria Market | Chronic Insomnia Market | Critical Limb Ischemia Market | Endometriosis Pain Market | Generalized Anxiety Disorder Gad Market | Hallux Valgus Market | Hemophilia B Market | Immunologic Deficiency Syndrome Market | Neuroblastoma Market | Neuromodulation Devices Market | Neurovascular Thrombectomy Devices Market | Osteosarcoma Market | Pemphigus Vulgaris Market | Progressive Familial Intrahepatic Cholestasis Market | Pruritus Market | Radiation Toxicity Market | Pulmonary Hypertension Associated With Interstitial Lung Disease Market | Cluster Headaches Market | Foot And Ankle Devices Market | Intravenous Immunoglobulin Market | Bile Duct Neoplasm Market | Blood Glucose Monitoring Systems Market | Rett Syndrome Market | Tissue Heart Valves Market | Cardiac Biomarkers Testing Devices Market | Subscription Healthcare | Hepatorenal Syndrome Market | Central Venous Catheters Market | Continuous Renal Replacement Therapy Machines Market | Nonalcoholic Steatohepatitis Market | Necrotizing Enterocolitis Market | Cardiac Amyloidosis Market | Artificial Iris Market | Aortic Aneurysm Stent Grafts Market | Polypoidal Choroidal Vasculopathy Market | Adrenal Crisis Market | Hearing Implants Market | Image Guided Surgery Devices Market | Angioedema Market | Bladder Cancer Market
Related Healthcare Services
Healthcare Competitive Intelligence Services
Healthcare Asset Prioritization Services
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Artificial Intelligence
Kazakhstan Government Delegation Visited SUPCON
HANGZHOU, China, Sept. 29, 2024 /PRNewswire/ — On September 26, a delegation from the Ministry of Digital Development, Innovations and Aerospace Industry of the Republic of Kazakhstan, led by Minister Madiyev Zhaslan, visited SUPCON. SUPCON’s Chairman and President, Mr.Cui Shan, warmly welcomed the delegation.
The Kazakhstan government representatives expressed their appreciation and recognition of SUPCON’s expertise and innovation in intelligent manufacturing, digital transformation, and industrial AI.
Madiyev Zhaslan expressed a strong interest in industrial AI technologies of SUPCON, particularly their applications in intelligent and low-carbon facilities. He looks forward to exploring extensive collaboration with SUPCON across various sectors in Kazakhstan.
Cui Shan emphasized that as a leading industrial AI company with a global presence, SUPCON will leverage its technological advantages to meet Kazakhstan’s industry development requirements and trends, injecting new momentum into the country’s industrial digitalization.
In 2023, SUPCON established a subsidiary in Kazakhstan as its Central Asia regional headquarters and set up a localized operational system. SUPCON will continue to invest in the long-term development of the Central Asia region, contributing further wisdom and strength to the industrial digital transformation in Kazakhstan and beyond.
Photo – https://mma.prnewswire.com/media/2518470/image_5022684_18905906.jpg Photo – https://mma.prnewswire.com/media/2518471/1.jpg
View original content:https://www.prnewswire.co.uk/news-releases/kazakhstan-government-delegation-visited-supcon-302261857.html
Artificial Intelligence
Huawei Peer-Recognized as a 2024 Gartner® Peer Insights™ Customers’ Choice for Enterprise Wired and Wireless LAN Infrastructure
SHENZHEN, China, Sept. 29, 2024 /PRNewswire/ — On September 24, 2024, Huawei announced that it has been peer-recognized a 2024 Gartner® Peer Insights™ Customers’ Choice in the Voice of the Customer for Enterprise Wired and Wireless LAN Infrastructure thanks to its Xinghe Intelligent Campus offerings. This marks the fifth year in a row that Huawei has received this distinction. Notably, Huawei receives Customers’ Choice distinctions in four of the six customer segments: Midsize Enterprise (50M – 1B USD); Public Sector, Government and Education; Asia/Pacific; and Europe, the Middle East and Africa.
As of June 30, 2024, customers across diverse sectors — including manufacturing, IT services, education, and telecommunication — have reviewed Huawei’s complete Xinghe Intelligent Campus offerings on the Gartner Peer Insights platform. We believe their impressive feedback showed global recognition of Huawei from the industry influence, deployment scales, and mature commercial use perspectives.
“We’re thrilled to be named a Gartner® Peer Insights™ Customers’ Choice for Enterprise Wired and Wireless LAN Infrastructure again,” said Shawn Zhao, President of Huawei’s Campus Network Domain. “Recently, Huawei launched the newly upgraded Xinghe Intelligent Campus that takes wireless, application, and O&M experience to new levels with AI technologies, ultimately accelerating the digital transformation of enterprises.”
Looking ahead, Huawei will further innovate Xinghe Intelligent Campus offerings from wireless, application, and O&M experience upgrade perspectives, helping all industries stride to the future of experience-centric intelligent campus networks.
For more about Gartner® Peer Insights™ Customers’ Choice, visit: https://www.gartner.com/reviews/market/enterprise-wired-wireless-lan-access-infrastructure
Disclaimer:
Gartner, Voice of the Customer for Enterprise Wired and Wireless LAN Infrastructure, Peer Contributors, 12 September 2024
Gartner, Peer Insights, Magic Quadrant and Customers’ Choice badge are trademarks of Gartner, Inc. and/or its affiliates. All rights reserved. Gartner Peer Insights content consists of the opinions of individual end users based on their own experiences, and should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Photo – https://mma.prnewswire.com/media/2518425/image.jpg
View original content:https://www.prnewswire.co.uk/news-releases/huawei-peer-recognized-as-a-2024-gartner-peer-insights-customers-choice-for-enterprise-wired-and-wireless-lan-infrastructure-302261856.html
Artificial Intelligence
Huawei Wen Tong: 6G Needs to Embrace AI for Shaping Future Network
SHENZHEN, China, Sept. 29, 2024 /PRNewswire/ — At the 6G Conference held in Istanbul, on September 24, 2024, Dr. Wen Tong, Huawei Wireless CTO, delivered a keynote speech on 6G standardization and innovation. With the release of the ITU-R 6G vision framework, the 3GPP will start 6G standardization in 2025. “6G is a new generation of mobile technology, not a simple upgrade of 5G, it should bring new value to users,” said Dr. Tong, “6G is a true intergenerational technological disruption. 6G standard, key technologies, and network architecture should be re-defined based on application scenarios and requirements from 2030 to 2040. 6G should not be another way to implement 5G. Instead, 6G should embrace the AI revolution with a quantum leap and generate new values for the consumers. In this way, 3GPP standards can truly realize the 6G vision and create greater value for the entire industry.”
Centered “6G Standardization Direction” and “6G Innovation Driving Force”, Dr. Tong shared important views on the future architecture, terminal development, and key technologies of 6G.
In terms of architecture design, 6G should go beyond Service-Based Architecture and move towards Application-Driven Network.
5G has already achieved market success and continues to evolve towards 5G-Advanced. 6G will not simply reuse 5G network architecture, without generational and fundamental innovations, which will limit the mobile industry’s aspiration and imagination to dive the innovation in the 6G era. 6G must have obvious cross-generational characteristics and technical breakpoint.
On the core side, reusing the 5G core network will hinder the innovation in AI. We should use Agentic-AI based technology to re-architect 6G Core that goes beyond 5G Service-Based Architecture and support the foundational capabilities of AI, Sensing and NTN , and thus evolve towards the Application Driven Network .
In terms of terminal evolution, 6G user device calls for a breakthrough to lead the success of the entire industry chain.
It is the law of the mobile industry to drive the evolution of the market with the pioneering technology. The 6G networks and 6G terminals must meet the requirements of consumers and vertical industries in the 6G market phase from 2030 to 2040.
Currently, smartphones are evolving to AI terminals to usher in the mobile AI era. In post-MBB era, breakthroughs in terminal technologies will be the key to the evolution of the mobile industry. Therefore, 6G user device calls for a breakthrough towards “Full-AI”, thus to drive 6G network upgrade and the success of the entire industry ecosystem.
In terms of technology development, AI will become a key enabler for 6G with network paradigm shifting.
Twenty years ago, the Internet was the enabler of the technology innovations. Mobile communications embraced the Internet and achieved great business success. Today, AI maybe the disruptive enabler of the latest technology innovations.
6G should embrace the AI revolution with a quantum leap. However, 6G networks should not be limited to generative AI, Artificial General Intelligence (AGI) and Embodiment-AI are the main directions of future AI development. Therefore, AGI should run through the whole process of sensing, reasoning, decision, and action of terminals, wireless networks, and core networks of 6G, to welcome the arrival of a new network paradigm.
At the end, Dr. Tong Wen emphasized the relationship between 5G and 6G: “The global 5G deployment is on the rise and evolving to 5G-Advanced, which not only meets the current requirements of operators, but also protects their investment. Therefore, 6G technologies should not overlap with 5G in technologies and market space. The specifications, technologies, and architecture of 6G must be based on the scenarios and requirements from 2030 to 2040. We should focus on true generational technology disruption, embrace the new opportunities brought by AI, expand the mobile industry in the next generation.”
Photo – https://mma.prnewswire.com/media/2518236/Huawei_Wireless_CTO_Tong_Wen_Gave_Keynote_Speech_at_6G_Conference_at_Istanbul__T_rkiye.jpg
View original content:https://www.prnewswire.co.uk/news-releases/huawei-wen-tong-6g-needs-to-embrace-ai-for-shaping-future-network-302261758.html
-
Uncategorized2 days ago
MC Digital Realty wins Frost & Sullivan’s 2024 Japan Data Center Services Company of the Year Award
-
Artificial Intelligence2 days ago
CluePoints Launches Medical & Safety Review (MSR) Software to Revolutionize Clinical Data Review
-
Artificial Intelligence6 days ago
EC-Council Unleashes AI-Powered Ethical Hackers on Cybercrime
-
Artificial Intelligence6 days ago
IBM and NASA Release Open-Source AI Model on Hugging Face for Weather and Climate Applications
-
Artificial Intelligence6 days ago
Happiest Minds’ MD & CFO, Venkatraman Narayanan, recognized as the Leading CFO of the Year at the CII CFO Excellence Awards 2023-24
-
Artificial Intelligence6 days ago
SSCL partners with PolyAI to empower next-generation customer experience
-
Artificial Intelligence6 days ago
Hospital in Greenland chooses Sectra’s radiology solution–enhanced cross-country collaboration for improved patient care
-
Artificial Intelligence6 days ago
BITBOT1000 Revolutionizes the Digital Market Landscape with AI-Driven Solutions